Number of Securities Underlying
Unexercised Options: Exercisable and
Unexercisable. These columns set forth, for each NEO
and for each grant made to the officer, the number of shares of the
Company’s common stock that could be acquired upon exercise of
outstanding options at the end of fiscal 2022. The vesting schedule
for each option with unexercisable shares is shown under
“Vesting Schedule” below.
The vesting of options held by the NEOs may be accelerated in the
circumstances described under the section “Executive Compensation — Compensation Tables —
Potential Payments and Rights on Termination or Change in
Control” below.
Number; Market Value of Units of
Stock That Have Not Vested. These columns report the
number and market value, respectively, of shares underlying each
grant of restricted stock units to each officer that is not subject to performance vesting
conditions nor the test to assure eligibility for deduction
pursuant to Section 162(m). The number of shares includes
dividend equivalent units that have accrued for dividends payable
through October 1, 2022. The market value is equal to the
number of shares underlying the units times the closing market
price of the Company’s common stock on September 30, 2022, the
last trading day of the Company’s fiscal year. The vesting schedule
for each grant is shown below, with grants identified by the letter
following the number of shares underlying the grant. Vesting of
restricted stock units held by NEOs may be accelerated in the
circumstances described under the section “Executive Compensation — Compensation Tables —
Potential Payments and Rights on Termination or Change in Control” below.
Number; Market Value of Unearned
Units That Have Not Vested. These columns set forth
the target number and market value, respectively, of shares of the
Company’s common stock underlying each restricted stock unit award
held by each NEO that is subject to performance-based vesting
conditions and/or the test to assure eligibility for deduction
pursuant to Section 162(m). The number of shares includes
dividend equivalent units that have accrued for dividends payable
through October 1, 2022. The market value is equal to the
number of shares underlying the units multiplied by the closing
market price of the Company’s common stock on September 30,
2022, the last trading day of the Company’s fiscal year. The
vesting schedule and performance tests and/or the test to assure
eligibility under Section 162(m) are shown in “Vesting Schedule” below.
Vesting Schedule.
The options reported above that are not yet exercisable and
restricted stock unit awards that have not yet vested are scheduled
to become exercisable and vest as set forth below.
(A) Unless otherwise noted, stock options and restricted stock
units granted before December 2020 will vest 25% on each of the
first four anniversaries of the grant date. Grants made in or after
December 2020 will vest one-third on each of the first three
anniversaries of the grant date.
(B) Amounts may not sum to total due to rounding.
(C) PBUs will cliff vest on the third anniversary of grant date,
based on 3-year TSR versus
S&P 500 and absolute ROIC tests for each of the fiscal years in
the 3-year period (targets
set each year). Grants before 2020 for Ms. McCarthy are
subject to performance under Section 162(m).
(D) While restricted stock units will vest 25% on each of the first
four anniversaries of the grant date for grants made before
December 2020 and one-third
on each of the first three anniversaries of the grant date for
grants made in or after December 2020, grants before 2020 for
Ms. McCarthy are also subject to a performance test to assure
eligibility for deduction under Section 162(m).
(E) Restricted stock units granted February 28, 2020 in
connection with Mr. Chapek’s appointment as Chief Executive
Officer. The units are scheduled to vest on December 17, 2022
subject to satisfaction of a 3-year TSR test and 3 1-year ROIC tests, with the number of
units vesting depending on the level at which the tests were
satisfied.
(F) Unexercisable options will vest one-third on December 14, 2022,
December 14, 2023 and December 14, 2024.
(G) Restricted stock units will vest one-third on December 14, 2022,
December 14, 2023 and December 14, 2024.
(H) PBUs will cliff vest on December 14, 2024, based on
3-year TSR versus S&P
500 and absolute ROIC tests for each of the fiscal years in the
3-year period (targets set
each year).
42